The Abraaj Group partners with leading Pakistani diagnostics business IDC
The Abraaj Group (“Abraaj” or the “Group”), a leading investor operating in global growth markets, has announced that it has partnered with Islamabad Diagnostics Centre (“IDC” or the “Company”), a leading diagnostics chain in Pakistan, through its Funds.
“Increased healthcare awareness and a growing requirement for detecting lifestyle diseases is increasing the demand for diagnostics services across Pakistan. IDC is clearly positioned to capitalise on this growth, through its world class infrastructure and diagnostics technology, and its competent management team. This partnership is an important step for us in building our presence in the diagnostics space across South Asia,” said Hisham Moussa, Managing Director, The Abraaj Group.
Founded in 2003 by Dr. Rizwan Uppal, Assistant Professor of Medicine at Nafees Medical College, and his brothers Dr. Imran Uppal and Dr. Rehan Uppal, IDC is an affordable diagnostics business operating in 20 centres across Islamabad, Rawalpindi, Wah Cantonment and Hasanabdal. The Company is looking to expand its presence across Islamabad, Rawalpindi and additional cities in the Punjab province, with the aim of expanding its presence to over 50 centres in the next five years.
IDC marks Abraaj’s 4th investment in the diagnostics space globally and the first in Pakistan. Abraaj will leverage its expertise and relationships to help IDC roll out its presence across the Punjab region, develop partnerships with government and private hospitals, and expand its service offerings. Abraaj will also support IDC in identifying bolt-on acquisitions across the country and institutionalising its management team and board of directors. The partnership will allow IDC to procure its equipment and consumables as part of the wider healthcare platform and to benefit from its central investment into data, analytics and insight.
“14 years ago IDC started as a concept offering full medical diagnostics services on a 24 hours basis under one roof, with state of the art technologies. We have grown at an exponential rate since then and we have ambitious expansion plans for the years ahead to serve wider population groups, augment the healthcare needs of the community and create more job opportunities. We look forward to the partnership with The Abraaj Group which has an outstanding track record in healthcare and are jointly committed to delivering on the growth plans for IDC,” said Dr. Rizwan Uppal, Founder and Chief Executive Officer of IDC.
The Abraaj Group has a strong track record of investing in healthcare, having deployed over $1.2 billion globally in 29 investments across the healthcare spectrum in growth markets. In 2015, the Group exited its diagnostic platform in the Middle East, Integrated Diagnostics Holding, via an IPO on the London Stock Exchange.